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Abstract
 
Developing B cells undergo dramatic changes in their responses to chemoattractant cytokines
(chemokines) and in expression of chemokine receptors. Bone marrow pre–pro-B cells
 
(AA4.1
 
1
 
/natural killer 1.1
 
2
 
 Fraction A cells) and cells capable of generating pro-B colonies in
the presence of interleukin 7 and flt3 ligand migrate to thymus-expressed chemokine
(TECK), a response lost in later stages of B cell development. B cell–attracting chemokine 1
(BCA-1) responses correlate with CXC chemokine receptor (CXCR)5 expression, are first
displayed by a pro-B cell subset, are lost in pre-B cells, and then are regained just before and
after egress from the marrow. All peripheral B cell subsets, including follicular and germinal
center as well as marginal zone and peritoneal B1 B cells, respond to BCA-1, implying that
responsiveness to this follicular chemokine is not sufficient to predict follicle localization. Re-
sponses to the CC chemokine receptor (CCR)7 ligands secondary lymphoid tissue chemoat-
tractant (SLC) and macrophage inflammatory protein (MIP)-3
 
b
 
, implicated in homing to
lymphoid tissues, are upregulated before B cell exit from the marrow, but increase further in
the periphery and are shared by all peripheral B cells. In contrast, responsiveness to MIP-3
 
a
 
and expression of CCR6 are acquired only after emigration to the periphery and during mat-
uration into the recirculating B cell pool. Chemotaxis to stromal cell–derived factor 1
 
a
 
 is ob-
served at all stages of B cell differentiation. Thus, unique patterns of chemokine responses may
help define developing B cell populations and direct their maturation in the marrow and mi-
gration to the periphery.
Key words: B lymphocyte • chemokines • chemotaxis • bone marrow • hematopoiesis
 
Introduction
 
B cells provide a two-pronged defense against invading
pathogens. B cells internalize specific antigens via their sur-
face Ig (sIg)
 
1
 
 receptors, process the antigen into peptides,
and present the peptides to T cells in the context of the B
cells’ class II MHC. In this manner, they act as sentinels and
survey the body for the presence of nonself-antigens. If
nonself-antigens are detected, B cells undergo a complex
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Abbreviations used in this paper:
 
 APC, allophycocyanin; BCA-1, B cell–
attracting chemokine 1; BCS, bovine calf serum; BLC, B lymphocyte
chemoattractant; BM, bone marrow; CCR, CC chemokine receptor;
CXCR, CXC chemokine receptor; GC, germinal center; Flt3-L, flt3
ligand; HSA, heat stable antigen; HSC, hematopoietic stem cell; HEV,
high endothelial venule; LARC, liver and activation-regulated chemo-
kine; MCP, monocyte chemoattractant protein; MIG, monokine in-
 
duced by IFN-
 
g
 
; MIP, macrophage inflammatory protein; MZ, mar-
ginal zone; PerCP, peridinine chlorophyll protein; PNA, peanut
agglutinin; PP, Peyer’s patch; RANTES, regulated upon activation,
normal T cell expressed and secreted; SDF, stromal cell–derived factor;
sIg, surface Ig; SLC, secondary lymphoid tissue chemoattractant; SAv,
streptavidin; TARC, thymus and activation-regulated chemokine;
TECK, thymus-expressed chemokine. 
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developmental program to generate large quantities of
high-affinity neutralizing antibodies that help in clearing
the pathogen from the host. To encounter antigen and to
obtain help in generating a potent humoral response, the
fulfillment of these two complex tasks requires that B cells
migrate into specific areas at specific times during their de-
velopment. Although the physical site(s) of B cell precursor
development and differentiation in the bone marrow (BM)
remain poorly defined, mature peripheral B cell subsets oc-
cupy characteristic microenvironments or domains. The
major B cell microenvironment in all secondary lymphoid
tissues is the primary follicle. The follicle contains recircu-
lating naive B cells that sample secondary lymphoid organs
such as the spleen, LNs, and Peyer’s patches (PPs) for the
presence of nonself-antigens and contribute to T cell–
dependent humoral responses (1). In the spleen, an addi-
tional B cell population occupies the marginal zone (MZ) that
surrounds the white pulp and are positioned near the effi-
cient antigen-trapping marginal sinus macrophages. MZ B
cells are thought to sample blood-borne T cell–indepen-
dent antigens that flow through the marginal sinus (2–4).
They turn over more slowly than follicular B cells and re-
circulate poorly to other lymphoid organs (4, 5), but are
translocated rapidly into the splenic white pulp in response
to endotoxin stimulation (6). During active immune re-
sponses, the follicle or follicular mantle surrounds another
distinct B cell microenvironment, the germinal center
(GC). GCs are sites of antigen-driven proliferation, affinity
maturation, and memory B cell generation (7, 8). Finally,
serosal surface cavities are populated by B1 or CD5
 
1
 
 
 
B
cells, which may represent an alternative B cell develop-
ment pathway. They are the primary source of natural anti-
bodies and contribute to auto-antibody production in au-
toimmune diseases (9, 10). The unique and distinctive
microenvironmental location of each of these well-defined
B cell populations requires that they display differential
homing properties.
Chemotactic signals are thought to play important roles
in leukocyte navigation by regulating migration from the
blood into tissues, as well as subsequent microenvironmen-
tal localization within those tissues. The list of characterized
leukocyte chemoattractants has grown rapidly with the
identification of the chemoattractant cytokine (chemokine)
superfamily (11). Chemokines send directional signals to
leukocytes by binding to seven transmembrane receptors
that are coupled to pertussis toxin–inhibitable G
 
a
 
i
 
 G pro-
tein heterotrimers. Most leukocytes express multiple chemo-
kine and other chemoattractant receptors in overlapping pat-
terns as a function of their development and activation
state. Cells expressing multiple receptors can navigate in a
step-by-step fashion through spatial arrays of overlapping
chemokine and chemoattractant gradients (12). Thus, the
migration and microenvironmental targeting of leukocytes
are thought to be determined as a function (in part) of the
set of chemokines to which they can respond: their
chemokine response profile or “fingerprint.”
Several chemokines attract primary B cells or B cell lines
and have been hypothesized to play a role in the homing
 
and microenvironmental localization of B cell subsets at
different stages of antigen-independent and -dependent B
cell differentiation (13–20). To explore the signals that
guide B cells, we identified chemokines to which develop-
ing and mature B cells respond and assessed how those re-
sponses change as the B cells develop and populate various
locales throughout the body. Our results reveal dramatic
developmental switches in chemotactic response profiles
during B cell development and suggest that altered chemo-
tactic responses may play a major role in determining
the migration patterns of developing B cells emigrating to
the periphery after differentiation in the BM. Conversely, the
major peripheral mature B cell subsets (follicular, MZ, GC,
and B1 B cells) display surprisingly similar responses to the
known secondary lymphoid and follicular chemokines,
suggesting that microenvironmental localization in the pe-
riphery involves additional uncharacterized elements.
 
Materials and Methods
 
Mice. 
 
Male and female C57BL/6 mice were housed and
bred at the Veterans Affairs Palo Alto Health Care Systems mouse
facility under specific pathogen-free conditions.
 
Flow Cytometric and Chemokine Reagents.
 
The following anti-
bodies were used (specificities and modifications in parentheses),
all from PharMingen: RA3-6B2 (allophycocyanin [APC]-con-
jugated rat anti–mouse CD45R/B220); 145-2C11 (biotin-conju-
gated Armenian hamster anti–mouse CD3
 
e
 
); AF6-78 (PE-conju-
gated rat anti–mouse IgM
 
b
 
); 53-7.3 (PE-conjugated anti–mouse
CD5); 1D3 (PE-conjugated rat anti–mouse CD19); B3B4 (PE-
conjugated rat anti–mouse CD23); M1/69 (PE-conjugated rat
anti–mouse CD24 [heat-stable antigen, HSA]); 11-26c.2a (FITC-
conjugated rat anti–mouse IgD); II/41 (FITC-conjugated rat
anti–mouse IgM); 145-2C11 (FITC-conjugated Armenian ham-
ster anti–mouse CD3
 
e
 
); 7G6 (FITC-conjugated rat anti–mouse
CD21); M1/69 (FITC-conjugated rat anti–mouse CD24 [HSA]);
S7 (FITC-conjugated rat anti–mouse CD43); and PK136 (FITC-
conjugated rat anti–mouse NK1.1). Purified rabbit anti–mouse
CXC chemokine receptor (CXCR)5 was obtained from Dr. Ja-
son Cyster (University of California at San Francisco, San Fran-
cisco, CA), and biotin-conjugated goat anti–rabbit IgG was pur-
chased from PharMingen. Rat anti–mouse CXCR3 (5B4) and
CC chemokine receptor (CCR)6 (1C12) mAb supernatants were
obtained from LeukoSite, and biotin-conjugated mouse anti–rat
IgG H
 
1
 
L was purchased from Jackson Immunoresearch Lab-
oratories. Peridinine chlorophyll protein (PerCP)-conjugated
streptavidin (SAv; Becton Dickinson) was used to visualize bio-
tinylated anti–mouse CD3
 
e
 
, anti–mouse CXCR3, anti–mouse
CXCR5, and anti–mouse CCR6. FITC-conjugated peanut ag-
glutinin (PNA; EY Laboratories) was used to visualize GC cells.
Technical grade rat IgG was purchased from Sigma Chemical Co.
The following chemokines were purchased from PeproTech:
recombinant mouse eotaxin, human I-309, mouse JE (monocyte
chemoattractant protein [MCP]-1), mouse KC (Gro-
 
a
 
), human
macrophage inflammatory protein (MIP)-3
 
a 
 
(liver and activa-
tion-regulated chemokine [LARC]), mouse regulated on activa-
tion, normal T cell expressed and secreted (RANTES), and hu-
man thymus and activation-regulated chemokine (TARC). The
following chemokines were purchased from R&D Systems: re-
combinant human B cell–attracting chemokine 1 (BCA-1), re-
combinant mouse B lymphocyte chemoattractant (BLC), mouse 
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monokine induced by IFN-
 
g 
 
(MIG), mouse MIP-1
 
b
 
, rat MIP-
3
 
a
 
 (LARC), mouse MIP-3
 
b
 
 (EBV-induced molecule 1 ligand
chemokine [ELC]), mouse secondary lymphoid tissue chemoat-
tractant (SLC, 6Ckine), and mouse thymus-expressed chemokine
(TECK). Human stromal cell–derived factor (SDF)-1
 
a
 
 was either
provided by Gryphon or purchased from PeproTech.
 
Lymphocyte Isolation.
 
6–10-wk-old mice of both sexes were
killed by cervical dislocation. Peripheral LNs (subiliac, proper ax-
illary, accessory axillary, and cervical), mesenteric LNs, PPs, and
spleen were harvested, minced with scissors in RPMI/10% bo-
vine calf serum (BCS), and pressed through a wire mesh screen
with a rubber syringe plunger. Peritoneal cavity cells were har-
vested by injecting 10 ml of RPMI/10% BCS into the peritoneal
cavity using a 27-gauge needle, agitating the cavity periodically
for 5 min, and removing the lymphocyte-rich solution with a 19-
gauge needle. BM cells were harvested by dissecting the femur
and tibia, removing all muscle from the bone, cutting the ends off
the bones, flushing with 3 ml of RPMI/10% BCS through both
ends of the bone, and passing the disrupted marrow though a
wire mesh screen. Splenocytes and BM cells were depleted of
erythrocytes by lysis in ACK buffer (5 min at room temperature).
The lymphocytes were allowed to incubate in RPMI/10% BCS
for 1 h at 37
 
8
 
C in a CO
 
2
 
 incubator in T-75 flasks to remove tis-
sue culture flask adherent cells and to allow time for resensitiza-
tion of potentially desensitized chemokine responses.
 
Chemotaxis Assay and Quantitation.
 
Chemotaxis assays were
performed in 5-
 
m
 
m pore transwell inserts as described by Camp-
bell et al. (21), with the following modifications. Chemokines
were used at the following concentrations: 500 nM BCA-1, 1
nM JE, 100 nM MCP-3, 100 nM MIG, 10 nM MIP-1
 
a
 
, 3 nM
MIP-1
 
b
 
, 100 nM MIP-3
 
a
 
, 100 nM MIP-3
 
b
 
, 100 nM
RANTES, 50 nM SDF-1
 
a
 
, 100 nM SLC, and 300 nM TECK.
The chemotaxis assay proceeded for 2 h, a known number of
counting beads were added to each chemotaxis well after Trans-
well insert removal, and the contents of the chemotaxis well
were transferred to a polypropylene pointed bottom tube. The
beads and cells were centrifuged at 200 
 
g
 
 for 10 min, excess me-
dium was removed, and the cells were resuspended in 25 
 
m
 
l of
cold Staining Buffer (PBS/1 mM MgCl
 
2
 
/1 mM CaCl
 
2
 
/0.1%
NaN
 
3
 
/2% Fraction V BSA) containing 30 
 
m
 
g of rat IgG (Sigma
Chemical Co.). The cells were incubated on ice for 15 min and
25 
 
m
 
l of the appropriate antibody cocktail was added. The cells
were further incubated on ice for 30 min, washed with 3 ml of
Staining Buffer, centrifuged, and incubated with 50 
 
m
 
l of Staining
Buffer containing 2.5 
 
m
 
l Sav-PerCP for 30 min. The cells were
either washed, centrifuged, and analyzed by flow cytometry
(non–PNA-stained cells), or incubated with 50 
 
m
 
l of PNA-FITC
for 4–6 min, stopped by addition of 3 ml of PBS/2% formalde-
hyde or Staining Buffer, centrifuged, and analyzed by flow cy-
tometry (for some PP B cell staining).
 
Chemokine Receptor Staining.
 
The indicated lymphoid organs
were disrupted and lymphocytes were isolated as described. The
cells were incubated for 1 h at 37
 
8
 
C to remove tissue culture
plate–adherent cells. 5 
 
3 
 
10
 
5
 
 lymphocytes were stained with ei-
ther purified rabbit anti–mouse CXCR5 polyclonal antibody at
1:25 dilution or purified rabbit anti-R–ras (0.5 
 
m
 
g) as a negative
control in 25 
 
m
 
l of Staining Buffer (22). Cells were washed and
stained with biotin-conjugated goat anti–rabbit IgG. Cells were
washed, blocked with 30 
 
m
 
g rat IgG, and incubated with the ap-
propriate cocktail of conjugated antibodies (and SAv-PerCP) to
visualize the relevant B cell populations.
10
 
6
 
 lymphocytes were stained with supernatants from either rat
anti–mouse CXCR3 mAb, rat anti–mouse CCR6 mAb, or irrel-
 
evant control supernatants (HECA-452, MK2.7). Cells were
washed and stained with biotin-conjugated mouse anti–rat IgG
H
 
1
 
L. Cells were washed, blocked with 30 
 
m
 
g rat IgG, and incu-
bated with the appropriate cocktail of conjugated antibodies (and
SAv-PerCP) to visualize the relevant B cell populations.
During chemokine receptor staining of the splenic Transition
1 population, anti–mouse CD3
 
e
 
-FITC, was included with B220-
APC, CD23-PE, and CD21-FITC to prevent B220
 
1
 
 T cells
(which do not have CD23 or CD21) from contaminating the
Transition 1 population (B220
 
1
 
CD23
 
2
 
CD21
 
2
 
/lo
 
). During chemo-
kine receptor staining of PP GC B cells, B220
 
1
 
 T cells were
excluded from analysis by staining with B220-APC, CD19-
PE, and PNA-FITC because B cells but not B220
 
1
 
 T cells ex-
press CD19.
 
Pro-B CFU Assay.
 
Unfractioned BM cells were isolated and
allowed to migrate to chemokines as described. Responding cells
from two chemotaxis wells (input 2E6 BM cells per Transwell
insert) were harvested, pelleted by centrifugation, and resus-
pended in 75 
 
m
 
l of RPMI/10% BCS. 1.35 ml of Methocult
M3630 containing 10 ng/ml recombinant human IL-7 (StemCell
Technologies Inc.) was aliquoted into 12 
 
3
 
 75 mm polypropy-
lene tubes, and 75 
 
m
 
l of recombinant murine flt3 ligand (Flt3-L;
R&D Systems) was added to give a final concentration of 50 ng/
ml Flt3-L (based on the methods of Hunte et
 
 
 
al. [23] and Veiby
et al. [24]). Responding cells were added to the Methocult mix-
ture, vortexed for 5 s, and aliquoted to 35 
 
3
 
 10 mm tissue cul-
ture polystyrene dishes using a 20-gauge needle. Multiple plates
were placed in a 150 
 
3
 
 15 mm plate containing an uncovered 35 
 
3
 
10 mm plate filled with water to prevent dehydration. The plates
were incubated in a 37
 
8
 
C incubator for 12–17 d. Colonies
were identified and counted using a dissecting microscope. Colo-
nies were harvested by removing them with a pipette and stained
with B220-APC, HSA-biotin/SAv-PerCP, CD19-PE, and Mac-
1–FITC to confirm the pro-B colony identification. The TECK-
responding pro-B CFUs only became apparent in the second
week of the assay, and they were tightly compact colonies com-
pared with a few very spread and disorganized B220
 
2
 
 colonies
that were found in all assays (including the Basal Medium control
plates). Many pro-B CFU colonies had a multilobed shape or
were a collection of three to six small colonies very close to-
gether. In all cases, these were counted as a single colony because
the relatively few number of colonies per plate did not suggest
that these colonies arose from multiple pro-B CFUs that happen
to settle out close together.
 
Results
 
Developmental Shifts in Chemokine Response Profiles during
B Cell Development in the BM.
 
B cells develop in the BM
through sequential developmental stages, from stem cells to
multipotent progenitors to pre–pro-B cells, to pro-B cells,
to pre-B cells, and finally to immature B cells. After com-
mitment to the B cell lineage, these stages have been asso-
ciated with particular surface phenotypic markers according
to Hardy et al. and Li et al. (25, 26). To explore the devel-
opmental control of the chemotaxis response profiles dur-
ing B cell development, we assessed the chemotactic re-
sponses of cells at each of these antigenically defined stages
(Fig. 1 A). A panel of chemokines was selected that bound
all of the currently described CC and CXC receptors (Ta-
ble I). Naive splenic 
 
md
 
1
 
 follicular B cells (
 
m 5 
 
sIgM heavy 
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chain, and 
 
d 5 
 
sIgD heavy chain), the most abundant ma-
ture peripheral B cell population, were evaluated in parallel
for comparison. Chemokines were titered from 0.1–100
nM (TECK was tested up to 1 
 
m
 
M and BCA-1 was tested
up to 2.5 
 
m
 
M), and results shown here reflect responses to
the concentrations that gave the optimal migration of BM
and peripheral B cells (concentrations used are given in the
legend of Table I). No significant difference was observed
in the dose–response curves to any chemokine by any B
cell subset analyzed in this paper (differences in the magni-
tude of response will be presented below).
None of the BM B cell populations nor the splenic 
 
md
 
1
 
B cells responded to eotaxin, TARC, I-309, or KC; migra-
tion to these chemokines at all concentrations tested was
indistinguishable from background migration (data not
shown). Non-B cell populations present in the BM and pe-
riphery responded to KC and TARC, confirming these
chemokines’ activity in our assay. MIP-3
 
a
 
, a well-charac-
terized peripheral lymphocyte-active chemokine also failed
to attract B lineage cells in the BM (but see next section).
All populations responded fairly equally to SDF-1
 
a
 
,
 
 con-
firming their competence to migrate under our experimen-
tal conditions (Fig. 1 C).
Interestingly, cells of pre–pro-B cell phenotype (B220
 
lo
 
HSA
 
2
 
/lo
 
AA4.1
 
1
 
NK1.1
 
2
 
; a subpopulation within the origi-
nal Fraction A population of Hardy et al. [25] that com-
bines the A1 and A2 fractions [26]) displayed substantial
migration to RANTES, JE (mouse MCP-1), MIG, and
TECK, chemokines associated with monocyte and/or acti-
vated T cell responses in the periphery. As illustrated in
Fig. 1 B, these cells responded well, but the response to
these chemokines was lost rapidly during progression to the
pro-B cell stage. B cell migration to these chemokines was
not observed in any more developed BM B cell or periph-
eral B cell population tested (follicular 
 
md
 
1
 
 B cells to the
right of the dotted line are shown as an example of a pe-
ripheral B cell population). In preliminary experiments,
MIP-1
 
a
 
, MIP-1
 
b
 
, and MCP-3 stimulated migration of
Fraction A BM B cells (data not shown). As these chemo-
kines are known to bind the same receptors as RANTES
Figure 1. The chemotactic fingerprint of B cells undergoes a dramatic
shift during development in the BM. (A) List of antigenically defined
stages in B cell development, according to Hardy et al. and Li et al. (refer-
ences 25, 26). (B) AA4.11NK1.12 Fraction A cells respond to RANTES,
JE, MIG, and TECK. Unfractioned BM cells were prepared and added to
inserts that were placed in wells containing the following chemokines:
100 nM RANTES, 1 nM JE, 100 nM MIG, or 300 nM TECK. Re-
sponding cells were harvested and stained with either B220-APC, unla-
beled AA4.1/mouse anti–rat IgG-biotin/SAv-PerCP, HSA-PE, and
NK1.1-FITC or AA4.1-APC, HSA-biotin/SAv-PerCP, B220-PE,
NK1.1-FITC to identify the AA4.11NK1.12 Fraction A population or
with combinations of B220-APC, IgMb-PE, HSA-PE, and CD43-FITC
to identify the later stages during B cell development. The data are the
mean 6 SEM from two to eight experiments. (C) Responses to peripheral
lymphoid chemokines appear late during BM B cell development. Same
procedure as above except the following chemokines were used: 100 nM
MIP-3a, 100 nM SLC, 100 nM MIP-3b, 50 nM SDF-1a, and 500 nM
BCA-1. The data are the mean 6 SEM from 3–15 experiments. All sym-
bols have error bars even though in some instances (i.e., Basal migration
and pro-B/BCA-1 migration) the error bars are smaller than the symbol.
Table I. Chemokines Used and Their Known Receptors
Chemokine Receptor
CCR1 MIP-1a, MCP-3
CCR2 JE (MCP-1), MCP-3
CCR3 Eotaxin
CCR4 TARC
CCR5 RANTES, MIP-1a, MIP-1b
CCR6 MIP-3a (LARC)
CCR7 MIP-3b (ELC), SLC (6Ckine)*
CCR8 I-309
CCR9 TECK
CXCR2 KC
CXCR3 MIG, SLC (6Ckine)*
CXCR4 SDF-1a
CXCR5 BCA-1 (BLC)
The chemokines were used at the following concentrations: 100 nM
MIP-1a, 100 nM MCP-3, 1 nM JE, 100 nm Eotaxin, 100 nM TARC,
100 nM RANTES, 3 nM MIP-1b, 100 nM MIP-3a, 100 nM MIP-3b,
100 nM SLC, 100 nM I-309, 300 nM TECK, 100 nM KC, 100 nM
MIG, 50 nM SDF-1a, or 500 nM BCA-1.
*Mouse SLC, but not human SLC, binds to CXCR3 (reference 64).1307 Bowman et al.
and JE (Table I), they were not used in subsequent experi-
ments.
To confirm that the Fraction A1/A2 responses to these
chemokines included B lineage cells, BM cells were
allowed migrate to each of these chemokines and the re-
sponding cells were placed into subsequent assays that fa-
cilitated growth of B lineage progenitors into colonies of
pro-B cells or pro-B CFUs by incubation with IL-7 and
Flt3-L in methylcellulose (23, 24). BM cells capable of gen-
erating pro-B CFUs responded to TECK (Fig. 2), whereas
RANTES and JE were much weaker at attracting pro-B
CFUs and no response over control was seen to MIG. The
TECK-responding cells required both IL-7 and Flt3-L to
generate colonies, as they yielded much fewer colonies in
the CFU assay with only IL-7 (data not shown). Therefore,
very early B lineage progenitors can respond to TECK and
this response is lost as B cells enter into the pro-B compart-
ment.
The loss of response to TECK during B cell develop-
ment occurred at the same stage as a gain of responsiveness
to chemokines associated with homing in secondary lym-
phoid organs: SLC, MIP-3b, and BCA-1 (16). Fig. 1 C
demonstrates that Fraction A1/A2 cells responded rela-
tively poorly to SLC and MIP-3b, chemokines implicated
in lymphocyte homing into peripheral lymphoid organs.
However, the responses increased dramatically in the fur-
ther differentiated BM B cell populations and in peripheral
md1 follicular B cells. Similar responses of pre-B and im-
mature B cells to MIP-3b have been reported by Ngo et al.
(17).
BCA-1 (BLC), a chemokine implicated in B cell entry
into the follicles of PPs and spleen (but interestingly, not
most PLNs [27]) is of particular interest in the context of B
cell behavior and microenvironmental homing. It is known
to attract the majority of B cells in the periphery, as well as
a small subset of CD41 T cells. We found that there is a
consistent but small response in the pro-B cell compart-
ment (P , 0.02 by Mann-Whitney rank sum test) that is
lost with progression to the pre-B cell stage. Regained
BCA-1 responsiveness in the immature B cell compart-
ment is consistently observed, but the magnitude was vari-
able from experiment to experiment. Mature peripheral
md1 B cells responded strongly to BCA-1.
The differential migration of gated B2201 BM subpopu-
lations to chemokines is illustrated in Fig. 3. Responding B
lineage cells (bold lines) are stained for various markers and
compared with the B lineage cells in the initial input popu-
lation (light line) after migration to SLC (Fig. 3, left) and
BCA-1 (Fig. 3, right). BM B cells that respond to SLC and
to BCA-1 are enriched for IgM expression, but they are
not identical populations. SLC-responding BM B cells
contain both IgM2 and IgM1 cells, with an enrichment in
IgM1 cells (Fig. 3 A). Conversely, only IgM1 cells are
found after chemotaxis to BCA-1 (Fig. 3 B), consistent
with later acquisition of BCA-1 responsiveness. As a con-
trol, we showed that incubation with various chemokines
did not change the surface level expression of any of the
markers used in this study (data not shown).
Receptor expression for one of the Fraction A1/A2
chemokines, MIG, was investigated in order to study the
unexpected chemotactic responses by these cells in more
detail. The only known receptor for MIG is CXCR3 (11),
and we used an anti–mouse CXCR3 mAb in combination
with the staining cocktails described above to visualize
CXCR3 expression at the different stages of B cell devel-
opment in Fig. 4 A. Fraction A1/A2 cells (Fig. 4 A, first
column) displayed very low to no staining with anti-
CXCR3 mAb, whereas the AA4.12 Fraction A subpopula-
tion displayed fairly uniform CXCR3 staining (data not
shown). No B lineage cells at later stages of development in
the BM or in the periphery (Fig. 4 A, last column) ex-
pressed CXCR3, consistent with their failure to migrate to
MIG (Fig. 1 B).
Figure 2. Early B cells respond to TECK. Unfractioned BM cells
were prepared and added to inserts that were placed in wells containing
the following chemokines: 100 nM RANTES, 1 nM JE, 100 nM MIG,
or 300 nM TECK. Responding cells were harvested and placed in meth-
ylcellulose containing IL-7 and Flt3-L. The number of colonies was
scored on days 12–17 by isolating colonies and staining with B220-APC,
HSA-biotin/SAv-PerCP, CD19-PE, and Mac-1–FITC to verify its
pro-B CFU classification. The data are the mean 6 SEM from three in-
dividual experiments.
Figure 3. Flow cytometry plots illustrate the selectivity of chemokine
responses by antigenically defined B cell subsets. Unfractioned BM cells
were prepared and added to inserts that were placed in wells containing
either 100 nM SLC (left) or 500 nM BCA-1 (right). Initial input (light
line) and responding (bold line) cells were harvested and stained with dif-
ferent combinations of B220-APC, IgMb-PE, and CD43-FITC. All pan-
els were gated on B2201 cells. The presented histograms were obtained
by overlaying individual histograms from three to four experiments, add-
ing them together using CELLQuest™ software (Becton Dickinson) to
obtain an average representative histogram, and normalizing them to the
peak cell number. CTX, chemotaxis.1308 Chemokine Responses during B Cell Development
As the biphasic response pattern of BM B cells to BCA-1
was unique among the peripherally important chemokines
tested, we further explored this chemokine–chemokine re-
ceptor interaction by determining the expression pattern of
the only known receptor for BCA-1, CXCR5 (14, 15).
No detectable expression of CXCR5 above background
was observed in the Fraction A1/A2 or pre-B cell popula-
tion (Fig. 4 B, first and third column). CXCR5 expression
was detectable on a subset of the pro-B cell population
(Fig. 4 B, second column), although the magnitude of the
shift was variable. The immature B cell population dis-
played CXCR5 (Fig. 4 B, fourth column) but the fre-
quency of expression was again variable, consistent with
their variable responses to BCA-1. In contrast, splenic md1
follicular B cells were uniformly and strongly CXCR51
(Fig. 4 B, last column). No staining above controls was ob-
served in any of the BM B cell populations (including pro-B
cells) harvested from CXCR5 knockout mice (data not
shown). Similar CXCR5 expression patterns for pre-B cell
and immature B cell populations have been reported by
Pevzner et al. (28) and Cyster et al. (22).
Taken together, these data demonstrate a shift in chemo-
tactic responses during B cell maturation in the BM, char-
acterized by the loss of responsiveness to TECK and an ini-
tial increase in responsiveness to the peripheral B cell
chemokines SLC, MIP-3b, and BCA-1 in the later stages of
BM B cell development (the immature BM B cell). How-
ever, neither the chemotactic responses nor the CXCR5 ex-
pression levels by immature B cells approached the high lev-
els displayed by naive splenic md1 B cells, suggesting that
further alterations in chemokine responses occur during de-
velopmental transition to mature peripheral B cells.
Major Shift to Peripheral Chemokine Responsiveness Associ-
ated with B Cell Emigration to Peripheral Lymphoid Tissues.
The large numbers of relatively short lived B cells that
have recently emigrated from the adult BM, and which are
transitioning into follicular B cells, can be found in the
spleen (4, 29, 30). Transition 1 B cells are B2201, sIgMhi,
sIgD2, CD21lo/2, and CD232; Transition 2 B cells are
B2201, sIgMhi, sIgDhi, CD21hi, CD23int; whereas, fully ma-
ture recirculating naive splenic B cells are B220hi, sIgMlo,
sIgDhi, CD21int, CD23int, and HSAlo (1, 4, 29, 30). We
asked whether the chemotactic responses of splenic transi-
tional B cells were different from those of either immature
BM B cells (B220loCD432sIgM1) or mature naive splenic
md1 follicular B cells (B220hisIgMlosIgDhi).
Fig. 5 A illustrates that, like the sIgM1 but immature
BM B cells that gave rise to them, Transition 1 recent BM
emigrants (B2201CD21lo/2CD232) to the spleen do not
respond to MIP-3a. However, B cells that have progressed
to Transition 2 B cells (B2201sIgMhisIgDhi), or that have
become members of the naive, recirculating pool of follic-
ular md1 B cells, show a greatly increased responsiveness to
MIP-3a. Responses to SLC, MIP-3b, SDF-1a, and BCA-1
exhibited by immature BM B cells were increased in the
Transition 1 population and increased further in both the
Transition 2 and the naive, splenic md1 B cells (Fig. 5 B).
Moreover, the responses of putative blood-borne periph-
eral B cells passing through the BM at the time of harvest
(Fraction F in the classification scheme of Hardy et al. [25],
B220hiCD432sIgM1) were indistinguishable from those of
splenic follicular md1 B cells (data not shown).
CXCR5 expression increases, paralleling BCA-1 re-
sponsiveness, as B cells exit the BM and progress through
the transitional stages into recirculating md1 follicular B
cells. Few immature BM B cells expressed significant levels
of CXCR5 (Fig. 5 D, first column), but a majority of
Transition 1 recent emigrants expressed CXCR5 (Fig. 5 D,
second column), and expression became more uniform and
more intense on Transition 2 and md1 follicular B cells
Figure 4. Chemokine recep-
tor expression by B cells at dif-
ferent stages of development in
the BM. Control staining
(dashed line) and antichemokine
receptor staining (bold line) for
CXCR3 (A), CXCR5 (B), and
CCR6 (C) are shown for the in-
dicated BM populations identi-
fied by their surface expression
of antigens listed in Fig. 1 A ex-
cept for Fraction A1/A2, which
were identified for chemokine
receptor staining purposes using
AA4.1-APC, B220-PE, and
HSA-FITC. Fraction (Fxn) A1/
A2 cells were identified as
B2201HSA2/loAA4.11.NK1.11
AA4.12 immature NK precur-
sors are excluded by these gates.
The data are representative of
two experiments.1309 Bowman et al.
(Fig. 5 D, third and fourth columns). CCR6 shows a dif-
ferent temporal pattern of acquisition compared with
CXCR5. CCR6 is undetectable on any BM B cell popula-
tion (Fig. 4 C, first four columns) including immature BM
B cells and the Transition 1 B cells to which they give rise
(Fig. 5 C, first and second columns, respectively). In con-
trast, all Transition 2 and recirculating md1 follicular B cells
display uniform CCR6 expression (Fig. 5 C, third and
fourth columns, respectively).
Chemotaxis Profiles of B Cells Occupying Distinct Microenvi-
ronmental Niches within Lymphoid Tissues: Follicular, Splenic
MZ, and GC Cells.  B cells occupying distinct anatomical
sites in lymphoid tissue can be distinguished by their anti-
genic phenotypes (31). Follicular B cells are B220hi
CD21intCD23int and are sIgDhi and sIgMlo (md1). In com-
parison, splenic MZ B cells are B2201CD21hiCD23lo/2 and
have low to zero IgD but high levels of IgM on their
surface (Fig. 6 A). In stimulated lymphoid tissues, such as
PPs, B cells in GCs are identified as B2201 cells that have
higher level expression of terminal galactosyl residues that
are recognized by the plant lectin peanut agglutinin
(PNAhi) compared with the surrounding B2201PNAlo fol-
licular mantle subset (Fig. 6 B [32–34]). In addition, GC B
cells are md2 compared with the follicular mantle md1 B
cells. In the experiments described here, we analyzed the
migration properties of cells in each of these regions indi-
vidually.
Splenic follicular (B220hiCD21intCD23int) and MZ
(B2201CD21hiCD23lo/2) B cells migrate with similar effi-
ciency to SLC, SDF-1a, and BCA-1 (Fig. 7 B). In con-
trast to IgM1 immature BM B cells and Transition 1 B
cells (Fig. 5 A), follicular B cells also migrate significantly
to MIP-3a (Fig. 7 A). MZ splenocytes also respond to
MIP-3a, but substantially less efficiently (Fig. 7 A). Follic-
ular B cells are also found in peripheral LNs, mesenteric
LNs, and PPs (also called follicular mantle B cells if GCs
are present); however, MZ B cells are far less numerous in
these organs compared with spleen (35). As expected, LN
(data not shown) and PP (Fig. 7, E and F) follicular B cell
subsets displayed very similar chemotactic fingerprints to
those of their splenic counterparts. The only difference
observed was that the MIP-3a responses of splenic fol-
licular B cells were less pronounced in the corresponding
PP (Fig. 7 E) and LN (data not shown but similar to PP)
populations. Chemotaxis profiles of CD3e1B2202 T cells
found in the corresponding organs are shown for com-
parison.
The expression of CCR6 and CXCR5 correlates with
the functional responses to MIP-3a and BCA-1 by splenic
B cells. In Fig. 7 C (second column), staining for CCR61
reveals a sharp, uniform peak of expression on CD21int
CD23int follicular B cells, whereas CD21hiCD232/lo MZ B
cells display broader and dimmer CCR6 expression levels
(Fig. 7 C, first column). Fig. 7 D shows a sharp, uniform
Figure 5. Continued maturation of B cell chemotactic responses after
exit from the BM. Unfractioned BM cells or splenic lymphocytes were
prepared and added to inserts that were placed in wells containing 100
nM MIP-3a (A) or 100 nM SLC, 100 nM MIP-3b, 50 nM SDF-1a, or
500 nM BCA-1 (B). Responding cells were harvested and stained with
combinations of B220-APC, CD3e-biotin/SAv-PerCP, IgMb-PE,
CD23-PE, IgD-FITC, and CD21-FITC to identify different cell popula-
tions. The data are the mean 6 SEM from two to six experiments. (C)
Control mAb staining (dashed line) and anti-CCR6 staining (bold line)
are shown for the indicated BM and splenic populations. The data are
representative of two experiments. (D) Control Ab staining (dashed line)
and anti-CXCR5 staining (bold line) are shown for the indicated BM and
splenic populations. The data are representative of two experiments. All
symbols have error bars even though in some instances (i.e., Basal migra-
tion) the error bars are smaller than the symbol.
Figure 6. Flow cytometric separation of anatomically distinct B cell
subsets. Unfractioned splenic lymphocytes (A) and PP lymphocytes (B)
were prepared and stained with B220-APC, CD3e-biotin/SAv-PerCP,
CD23-PE, and CD21-FITC for spleen or B220-APC, CD3e-biotin/
SAv-PerCP, and PNA-FITC for PPs. The data shown have been gated
on the B2201CD3e2 population.1310 Chemokine Responses during B Cell Development
peak of CXCR5 expression on both CD21intCD23int fol-
licular (second column) and CD21hiCD232/lo MZ (first col-
umn) B cells. The levels of CCR6 and CXCR5 on periph-
eral LN and PP Region 1 B cells are identical to the levels
observed on splenic follicular B cells (data not shown).
Similar CXCR5 expression by follicular and MZ B cells has
been observed by Cyster et al. (22). No detectable CXCR3
expression was observed on splenic or PP B cells (data not
shown).
We studied GC B cells in PPs, secondary lymphoid or-
gans of the gut wall, which are chronically stimulated by
their constant exposure to food-borne antigens and the in-
testinal microflora. PP GC B cells (B2201PNAhi) re-
sponded to SLC, SDF-1a, and BCA-1 as well as the unac-
tivated follicular mantle B cell population (B2201PNAlo),
with a slight reduction in the SDF-1a response (Fig. 7 F).
Interestingly, GC B cells in the PPs of C57BL/6 mice (the
principle strain studied here) displayed somewhat en-
hanced chemotaxis to MIP-3a (Fig. 7 E). In contrast, GC
B cells in the PPs of Balb/c mice displayed significantly
reduced MIP-3a responses compared with their follicular
mantle counterparts (data not shown). In spite of their rel-
atively efficient migration to MIP-3a, many C57BL/6
GC B cells lacked CCR6 expression (Fig. 7 C, fourth col-
umn), with only a small number displaying high levels
comparable to PP follicular B cells (Fig. 7 C, third col-
umn). PP GC B cells displayed uniform levels of CXCR5
expression (Fig. 7 D, fourth column) that were similar in
magnitude to splenic follicular (Fig. 7 D, second column)
and PP follicular mantle (Fig. 7 D, third column) B cells.
Similar chemotaxis and receptor expression data were ob-
tained when md2 staining was used to discriminate PP fol-
licular mantle and GC B cells (data not shown).
Chemotaxis Profiles of Extrafollicular Peritoneal Cavity B
Cells.  A unique type of B cell is found primarily in the
peritoneal and pleural cavities of the mouse. B1 or
Figure 7. Chemotactic responses of fol-
licular, MZ, and GC B cells. (A and B) Un-
fractioned splenic lymphocytes were added
to inserts that were placed in wells contain-
ing 100 nM MIP-3a (A), or 100 nM SLC,
50 nM SDF-1a, or 500 nM BCA-1 (B).
Responding cells were harvested, stained
with the mAbs, and gated on the follicular
and MZ regions shown in Fig. 6 A. The
data are the mean 6 SEM from three to
eight experiments. (C) Control mAb stain-
ing (dashed line) and anti-CCR6 staining
(bold line) are shown for the splenic
CD21hiCD232/lo MZ (first column),
CD21intCD23int splenic follicular B cells
(second column), B2201PNAlo PP follicular
mantle (third column), and B2201PNAhi PP
GC B cells (fourth column). The data are
representative of two experiments. (D)
Control Ab staining (dashed line) and anti-
CXCR5 staining (bold line) are shown for
the indicated splenic and PP populations
described in C. The data are representative
of two experiments. (E and F) Unfractioned
PP lymphocytes were prepared and added
to inserts that were placed in wells contain-
ing 100 nM MIP-3a (E) or 100 nM SLC,
50 nM SDF-1a, or 500 nM BCA-1 (F).
Responding cells were harvested, stained
with the mAbs, and gated on the follicular
mantle and GC regions shown in Fig. 6 B.
The data are the mean 6 SEM from two to
four experiments.1311 Bowman et al.
CD51Ly-11 B cells are part of the preimmune repertoire
and may arise via an alternative developmental pathway.
They are self-renewing (1) and are associated with autoim-
mune diseases and B cell leukemias and lymphomas (10).
Peritoneal B1 B cells are B220lo and most are CD51 and
CD431 (1). The conventional B cells (termed B2) in the
peritoneal cavity have higher levels of B220 and are CD52
and CD432. Both types of B cells from the peritoneal cav-
ity had zero to very low basal migration compared with
any of the other B cell populations we tested (Fig. 8, A and
B). Both B1 and B2 B cells responded to SLC, SDF-1a,
and BCA-1 equally well, though to a lesser degree than
splenic B cells (compare Fig. 8 B with Fig. 7 B), and their
response to MIP-3a was reduced compared with splenic B
cells (compare Fig. 8 A with Fig. 7 A). CCR6 expression
was demonstrated on both B1 and B2 cells, although back-
ground staining of B1 B cells was relatively high (Fig. 8 C).
Both B cell populations expressed high levels of the BCA-1
receptor CXCR5 (Fig. 8 D). Cyster et al. has also demon-
strated CXCR5 expression on peritoneal cavity B1 B cells
(22).
Discussion
A central tenet of current models of leukocyte trafficking
is that coordinated regulation of adhesive and migratory re-
sponses controls cellular positioning or homing in vivo
(36). In turn, this homing determines the leukocyte’s cellu-
lar and microenvironmental interactions, and therefore its
fate and function. For example, developmental switches in
homing receptor and vascular addressin expression have
been implicated in the maturation of peripheral lymphoid
tissue during the perinatal period (37) and in developmen-
tal and antigen-induced transitions in T cells (38, 39). We
show here that developing B lineage cells undergo dramatic
alterations in their chemotactic responses to different
chemokines, alterations that may help define particular
stages of B cell maturation and may regulate their cellular
and microenvironmental interactions, development, and/
or function. We will discuss our findings in relation to (a)
the major changes that occur during B lineage develop-
ment, including the unique expression of a TECK response
during an early B lineage stage and a dramatic switch to pe-
ripheral secondary lymphoid organ–expressed chemokine
responses associated with B cell export from the marrow
compartment, and (b) the patterns of chemokine responses
displayed by B cells occupying different microenvironmen-
tal niches in the periphery.
We first addressed the chemokine responses of B cells at
their earliest committed stage of development in the adult
BM. B cell genesis derives from dividing hematopoietic
stem cells (HSCs) that differentiate into progenitor cells,
which in turn give rise to various hematopoietic lineages.
The first identifiable BM cells committed to the B lineage
are Fraction A1/A2 (AA4.11NK1.12 cells within Fraction
A [25, 26, 40]); these cells still have their Ig genes in the
germline state but display the B lineage marker B220.
Surprisingly, we found that a significant fraction of
AA4.11NK1.12 Fraction A cells, unlike B lineage cells at
later stages of development, migrate in response to
RANTES, JE (mouse MCP-1), MIG, and TECK. These
chemokines attract monocytes (RANTES and JE) and sub-
sets of T cells (RANTES, JE, MIG, TECK) in the periph-
ery, but have no activity on mature B cells.
Limiting dilution analysis of B2202HSA2AA4.11CD41
multipotent progenitors demonstrated that a large number
of colonies derived from single cells gave rise to progeny
colonies containing both B cells and macrophages, suggest-
ing a close developmental relationship between monocytes
and B cells (40). These data, and the observation of bipo-
Figure 8. B1 (CD51) B cells respond to lymphoid tissue chemokines
but not significantly to MIP-3a. (A and B) Unfractioned peritoneal cavity
lymphocytes were prepared and added to inserts that were placed in wells
containing 100 nM MIP-3a (A) or 100 nM SLC, 50 nM SDF-1a, or 500
nM BCA-1 (B). Responding cells were harvested and stained with B220-
APC, CD3e-biotin/SAv-PerCP, CD5-PE, and CD43-FITC. The data
are the mean 6 SEM from two to four experiments. (C) Control mAb
staining (dashed line) and anti-CCR6 staining (bold line) are shown for
the indicated peritoneal cavity populations. The data are representative of
two experiments. (D) Control Ab staining (dashed line) and anti-CXCR5
staining (bold line) are shown for the indicated peritoneal cavity popula-
tions. The data are representative of two experiments.1312 Chemokine Responses during B Cell Development
tential precursors of B cells and macrophages in the fetal
liver (41), may explain the low level responses of AA4.11
NK1.12 Fraction A cells to seemingly monocytic che-
mokines if both cell types arose from a common precursor.
Interestingly, a recent report has shown that CXCR3 is
expressed on leukemic B cells from all patients with
chronic lymphocytic leukemia and is found on a subset of
other B cell leukemias and lymphomas (42). In other stud-
ies, we have found that the JE/MCP-1 response in Frac-
tion A cells is absent in CCR2-deficient mice, further con-
firming the association of functional responses with specific
chemokine receptor expression (Bowman, E., unpublished
results). However, the lack of significant response by
RANTES-, JE-, and MIG-responding cells in secondary
pro-B CFU assays (Fig. 2) lessens the emphasis we can
place on these chemokine responses in the scheme of B cell
development. Other non-B lineage cells within the Frac-
tion A gate including AA4.12NK1.11 immature NK pre-
cursors (26, 43) migrate very efficiently to these chemo-
kines, and the responses seen in the AA4.11NK1.12
population may be due to contaminating non-B lineage
cells that fall within the flow cytometry gates we have set.
AA4.11 Fraction A cells do not express consistently detect-
able levels of CXCR3 (Fig. 4 A) even though they consis-
tently migrated to MIG (Fig. 1 B). Either this population
expresses another undescribed MIG receptor or they may
express levels of CXCR3 that, while functional, are much
lower than those on CXCR31 AA4.12 Fraction A cells,
levels beneath our detection limits. Preliminary studies sug-
gest that earlier HSCs, like later stage B lineage cells shown
here, are also unresponsive to these chemokines (data not
shown).
TECK was the only chemokine that could effectively
migrate BM cells that would give rise to pro-B CFUs in
the presence of IL-7 and Flt3-L (Fig. 2), but not IL-7 alone
(data not shown). IL-7 alone stimulates the proliferation of
late pro-B cells and early pre-B cells, but early pro-B cells,
pre-B cells, and immature B cells are unresponsive (23).
Flt3-L can not stimulate the proliferation of any B lineage
population alone, but Flt3-L synergizes with IL-7 to in-
crease the growth of Lineage2/Sca-11 BM cells (a hetero-
geneous population of cells containing B cell progenitors
before they express B220 [24]) and the B cell progenitors
among the B220loCD431HSA2/lo Fraction A population
(23). These data combined suggests that TECK selectively
attracts very early B2201 B lineage progenitors (23) and/or
B2202 BM cells with potential to develop into B2201 B
cells (24), as these cell types require both IL-7 and Flt3-L
for growth into pro-B colonies.
It is attractive to postulate that responsiveness to TECK
(and potentially RANTES and JE) by B lineage progenitors
may help target them into supportive specialized niches ap-
propriate to their developmental stage, and that downregu-
lation of this (these) response with subsequent maturation
would then allow their progression to different marrow
microenvironments. However, B lineage progenitors may
respond to these chemokines not only as chemotactic
agents, but also as growth promoting and/or arresting cy-
tokines. Several chemokines have been demonstrated to
have potent effects on the growth of BM progenitors (es-
pecially myeloid progenitors) (44–48) and a feedback sys-
tem has been hypothesized whereby chemokines produced
in the periphery control the further production of different
leukocyte lineages. Therefore, B lineage progenitor re-
sponses to these chemokines may play a role in the total B
cell output by the BM by regulating the total number of B
lineage cells that are allowed to develop.
As B cells progress through their developmental pro-
gram, there is a dramatic switch in their chemotactic pro-
files. AA4.11NK1.12 Fraction A cells convert into pro-B
cells (Fraction B and C) with increasing D-JH but not V-D-
JH rearrangement (25). Concomitant with Ig gene recom-
bination, these cells lose their response to TECK and ac-
quire responsiveness to BCA-1. Pro-B cells progress into
pre-B cells (Fraction D) with increasing V-D-JH and V-Jk
rearrangement (25). These cells lose the BCA-1 response
present in pro-B cells, but still possess the same small re-
sponse to the CCR7 ligands exhibited by both AA4.11
NK1.12 Fraction A cells and pro-B cells. Pre-B cells differ-
entiate into immature B cells (Fraction E) with fully rear-
ranged Ig-encoded DNA, completing the BM stage of B
cell development (25). These sIgM1 immature B cells mi-
grate better to the CCR7 ligands SLC and MIP-3b than
their pre-B cell precursors, and reacquire responsiveness to
BCA-1. CXCR5 expression mirrors BCA-1 responsive-
ness, with a minor proportion of pro-B cells and immature
B cells expressing detectable levels of the receptor and mi-
grating to BCA-1. Thus, developing B cells undergo a va-
riety of developmental alterations, from the on/off re-
sponse to TECK (and potentially RANTES, JE, and MIG),
the on/off/on again response to BCA-1, and the progres-
sive increases in responses to the secondary lymphoid hom-
ing–associated chemokines, SLC and MIP-3b. Similar
conclusions concerning CCR7 ligands have been made in
the human system by Kim et al. (49), who demonstrated
that the CCR7 ligands SLC and MIP-3b induce the mi-
gration of late stage B cell progenitors (pre–B II, immature,
and mature B cells), but not early pro/pre–B I cells.
Interestingly, B lineage cells at all stages of development
migrate with similar efficiency to SDF-1a, at least when as-
sayed at the optimal chemotactic concentrations used here.
This finding of uniform SDF-1a responsiveness is similar
to that of Kim et al. (49). However, it contrasts with the
results by D’Apuzzo et al. (50); these authors report that
early B lineage cells from mouse BM migrate much better
to SDF-1a than do more developed B cells, and postulated
that SDF-1a selectively attracts and confines early B cell
precursors within the BM. The basis for this difference is
unclear. Our results and those of Kim et al. also raise the
possibility that apparent effects of SDF-1a and CXCR4 on
B cell retention in the BM may reflect secondary or indi-
rect effects, rather than a direct SDF-1a–mediated reten-
tion mechanism. One scenario would be that stromal-pro-
duced SDF-1a stimulates hematopoietic non-B cells in the
BM to produce the factor required to retain B cells in BM
until their development is complete, at which time the B1313 Bowman et al.
cells would lose responsiveness to this factor and exit the
BM. Reconstitution of lethally irradiated mice with
CXCR42/2 fetal liver cells (as performed by Ma et al. [51])
would leave both the hypothetical non-B cell and B lin-
eage cells incapable of responding to stromal-produced
SDF-1a. In this indirect manner, B lineage cells would not
be retained in the BM, but this would be due to the lack of
action of SDF-1a on the non-B cell, which then prevent
expression of the pro-retention factor, instead of a direct
SDF-1a–B cell interaction. Also unclear is the significance
of the increased SDF-1a responsiveness in B cells after exit
to the periphery, since CXCR42/2 lymphocytes migrate
to secondary lymphoid organs and repopulate their niches
efficiently (51).
Though sIgM1 immature BM B cells respond to SLC,
MIP-3b, SDF-1a, and BCA-1, the magnitude of the re-
sponses by B cells increases substantially after their migra-
tion to the spleen (i.e., as transitioning recent emigrants).
These heightened responses are further increased after pro-
gression of the splenic Transition 1 B cells into Transition 2
B cells. No further increase in responsiveness to these
chemokines is seen as Transition 2 B cells convert into the
naive, recirculating md1 B cells. In the case of BCA-1 re-
sponses, the increased chemotaxis is associated with an in-
crease in both the frequency and intensity of CXCR5 ex-
pression (Fig. 5, B and D).
BCA-1 is preferentially expressed by dendritic cells in B
cell follicles (14). Along with its receptor, CXCR5, it has
been postulated to control B cell entry into the follicular
environment (14, 15, 52). Consistent with studies of
CXCR5 expression on human B cells by Forster et al. (52),
we observed that peripheral B cells migrate better to BCA-1
than immature BM B cells, supporting an important role
for these molecules in peripheral B cell function. More-
over, we have found that (a) immature BM B cells respond
relatively poorly to BCA-1; (b) there is an increased BCA-1
response in splenic transitioning populations; (c) the re-
circulating pool of splenic B cells possesses the most robust
response to BCA-1 measured; and (d) CXCR5 expression
and responsiveness to BCA-1 characterize all the major pe-
ripheral B cell subsets, including MZ B cells and B1 B
cells—cells that are not associated with the follicular mi-
croenvironment. Together, these results indicate that
CXCR5 expression and BCA-1 responsiveness are not, in
and of themselves, sufficient to confer follicular localization
to B cells. It is important to consider this conclusion in
light of studies that demonstrated that CXCR5-deficient B
cells display selective follicular localization defects in PPs
and spleen (but not in most peripheral LNs, where follicu-
lar homing was normal [52]).Taken together with our find-
ing of CXCR5 expression and BCA-1 responsiveness by B
cells that are normally excluded from the follicular com-
partment, these data suggest that follicular localization may
be under complex (combinatorial) control as a function of
tissue site (and other factors), so that a contribution of
CXCR5 is essential in PPs and spleen, but is accessory or
redundant in most normal LNs. BCA-1 may have other
important functions in peripheral B cell biology as well.
The increasing responsiveness to SLC and MIP-3b dur-
ing B cell maturation in and after emigration from the BM
is of particular interest because these chemokines signal
through a common receptor, CCR7, and have been impli-
cated in directing peripheral lymphocyte homing. SLC but
not MIP-3b can also signal through CXCR3 (53), but this
receptor is not expressed by peripheral B cells. SLC is made
and displayed by high endothelial venule (HEV) cells (54,
55), can trigger rapid shear-resistant integrin-dependent ar-
rest of rolling lymphocytes (16, 56), and has been impli-
cated in the recognition and arrest of circulating lympho-
cytes on HEVs in PPs and LNs (55, 57). SLC and MIP-3b
are also expressed by stromal dendritic cells in T cell zones
of all secondary lymphoid organs (54). Although recent in
situ studies show that B cells do not require SLC or MIP-
3b signaling to arrest on HEVs in vivo (55), the ability of
all B cell subsets to respond to these chemokines may nev-
ertheless permit or facilitate their entry into lymphoid or-
gans from the blood, perhaps at the level of diapedesis as
evidenced by the poor homing of CCR72/2 B cells into
LNs and PPs compared with wild-type B cells (58). Inter-
estingly, SLC is also expressed by lymphatic endothelium
and has been implicated in lymphatic entry of activated
dendritic cells. It may play a similar role for lymphatic re-
cruitment of activated or memory lymphocytes in extra-
lymphoid tissues. Thus, the upregulation of MIP-3b and
SLC responses in association with B cell export to the pe-
riphery may facilitate mature B cell migration and circula-
tion through secondary lymphoid organs at multiple levels.
Importantly, all mature peripheral B cell populations, in-
cluding follicular and MZ B cells as well as GC and B1 B
cells, respond equally well to SLC and MIP-3b, as they
do to SDF-1a and BCA-1. Therefore, although these
chemokine responses may be critical to B cell trafficking in
the periphery, they appear unlikely to be responsible for
the specialized homing properties that target B cell subsets
to distinct microenvironments.
B cell responses to MIP-3a were unique, in that detect-
able chemotaxis to MIP-3a was limited to a subset of pe-
ripheral mature B cells. No migration to MIP-3a and no
CCR6 expression were observed in any BM B cell popula-
tion, including the most developed sIgM1 immature BM B
cell. Recently emigrated Transition 1 splenic B cells also
lacked CCR6 and did not respond to MIP-3a, but Transi-
tion 2 B cells and splenic follicular md1 B cells are uni-
formly CCR61 and migrate consistently (albeit at lower ef-
ficiency than the other peripheral chemokines tested).
Although only a subset of PP GC B cells display CCR6,
GC B cells respond well to MIP-3a, suggesting that the
CCR61 GC B cells have an enhanced migratory response
to this chemokine.
Our finding of significant MIP-3a responses in these
mature B cell population conflicts with the conclusions by
Liao et al. (59), who were unable to generate a calcium flux
with MIP-3a in human B cells in spite of low level uni-
form expression of CCR6, as revealed by mAb staining.
They proposed that B cells are unresponsive to MIP-3a.
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human lymphocytes (Campbell, J.J., unpublished data)
clearly demonstrate that B cells migrate to MIP-3a. More-
over, in recent studies, Tanaka et al. confirm our findings
that PP B cells migrate to MIP-3a and report an efficiency
of MIP-3a–induced chemotaxis similar to that observed
here (20).
MIP-3a is primarily expressed by epithelial cells, espe-
cially during inflammation or on epithelium associated with
lymphoepithelial organs such as PPs. For example, in
Northern blot analysis it is reportedly absent or only
weakly expressed in resting spleen and LNs, but it is detect-
able in inflamed tonsils, intestine, and appendices (lym-
phoid tissues intimately associated with epithelial surfaces
[20, 60–62]). In situ hybridization studies reveal high level
expression by antigen-recruiting epithelium in the lym-
phoepithelial tonsils and PPs (20, 61). MIP-3a expression
by such epithelium has been postulated to help recruit anti-
gen-presenting dendritic cells, and it may also help define
sites of B cell recruitment to epithelial-associated lymphoid
organs, including PPs and also bronchus-associated lym-
phoid tissue. Such a concept might provide teleological ex-
planation for the association of MIP-3a responses and
CCR6 expression with follicle-homing B cell populations.
There are only minor differences in the chemotactic re-
sponses between resting follicular mantle and antigen-reac-
tive GC B cells to the chemokines studied here. This con-
trasts with the results of Bleul et al. (63), who showed that
human tonsillar GC (CD381) B cells were unable to re-
spond to SDF-1a even though they express the SDF-1a
receptor CXCR4. We have extended their studies and ex-
amined the chemokine responsiveness of human tonsil B
cells to MIP-3a, SLC, and BCA-1 in addition to SDF-1a.
In each case, human tonsil GC B cells failed to respond to
any of the chemokines tested, whereas tonsillar non-GC
CD382 B cells responded robustly (Campbell, J.J., unpub-
lished observation). This discrepancy in functional re-
sponses may be due to a species difference between mice
and humans, or alternatively may reflect differences in GCs
from different lymphoid organs. In this context, it is rele-
vant that we observed consistent significant strain-depen-
dent differences in the GC B cell responses to MIP-3a,
suggesting genetic variability in GC responses.
Receptor expression alone has not proven an adequate
parameter to predict a cell’s chemotactic potential. Forster
et al. reported that human tonsil GC CD381 B cells express
CXCR5 on their surface (52) and Bleul et al. reported that
human tonsil CD381 B cells express CXCR4 (63) even
though these cells were unresponsive to the chemokines
BCA-1 and SDF-1a (see above paragraph). We conclude
that the functional measurement of chemotaxis is the only
way to determine the chemotactic response profile for any
given cell population. By assessing the correlation between
function and surface expression of known receptors (as pre-
sented here for CCR6, CXCR3, and CXCR5), a second-
ary question can be investigated: Which receptors mediate
the distinctive chemotactic fingerprints of cells? However,
potential involvement of unidentified receptors (as yet)
must always be kept in mind.
Both B1 and B2 B cells from the mouse peritoneal cavity
respond to SLC, SDF-1a, and BCA-1 with equal effi-
ciency (albeit not as well as splenic follicular B cells). How-
ever, unlike splenic B cells, there was no response of B1 B
cells and very little response of B2 B cells to MIP-3a even
though both cell types expressed CCR6. It was surprising
that B1 B cells, which are not found in great quantities in
secondary lymphoid organs, can nevertheless respond to
the follicle-associated chemokine BCA-1 and the HEV-
associated chemokine SLC. If B1 B cells do arise through a
unique developmental program (9, 10), that program still
enables them to respond to all the same chemokines (ex-
cept MIP-3a) to which more conventional B cells respond.
As it seems unlikely that these lymphoid organ chemokines
play a role in recruiting cells into the peritoneal or other se-
rosal cavities, they may function in allowing B1 B cells to
migrate or circulate through lymphoid tissues themselves.
In conclusion, we have uncovered a dynamic regulation
of the chemotactic responses of B cells as they progress
through development (Fig. 9). Responses to secondary
lymphoid chemokines increase progressively during B cell
differentiation in the BM and are upregulated even further
in cells that have progressed into fully mature recirculating
peripheral B cells. The remarkable similarity in chemotactic
responses to the peripheral chemokines by different mature
peripheral B cell subsets (follicular, MZ, GC, and B1 B
cells) was unexpected in light of their unique patterns of
microenvironmental homing. The only exception was the
response to MIP-3a, which was mainly detected in follicle-
associated md1 and GC B cells. We conclude that these
chemokines and their receptors likely act in combination
with other chemoattractants, signaling, and adhesion mole-
cules to control the microenvironmental homing and the
localization of distinct B cell subsets in the periphery. In
contrast to the similar chemotactic fingerprints of microen-
vironmentally defined peripheral B cell populations, devel-
oping BM B cells display striking, stage-specific chemokine
Figure 9. Schematic depiction of the acquisition and loss of chemokine
responsiveness as B cells develop in the BM and migrate to the periphery.1315 Bowman et al.
response profiles. The dramatic switches in chemokine re-
sponses in maturing B cells suggest that chemoattractant re-
sponsiveness may play an important role in B cell develop-
ment.
We thank J. Cyster, E. O’Hara, C. Kim, J. Kim, M. Williams, and
K. Youngman for critical reading of the manuscript. 
This work was supported by National Institutes of Health grants,
an Award from the Department of Veterans Affairs (to E.C.
Butcher), and by the FACS® Core Facility of the Stanford Diges-
tive Diseases Center under National Institutes of Health grant
DK38707. E.P. Bowman was supported by U.S. Public Health Ser-
vice grant 5T32CA09151 and was a recipient of an Arthritis Foun-
dation Postdoctoral Fellowship. J.J. Campbell was supported by
National Institutes of Health Cancer Etiology, Prevention, Detec-
tion, and Diagnosis grant 5T32CA090302, National Institutes of
Health Individual National Research Service Award 1F32AI08930,
and was a recipient of an Arthritis Foundation Postdoctoral Fellow-
ship. R.R. Hardy was supported by National Institutes of Health
grant AI26782.
Submitted: 26 July 1999
Revised: 28 January 2000
Accepted: 31 January 2000
References
1. Goodnow, C.C., J.G. Cyster, S.B. Hartley, S.E. Bell, M.P.
Cooke, J.I. Healy, S. Akkaraju, J.C. Rathmell, S.L. Pogue,
and K.P. Shokat. 1995. Self-tolerance checkpoints in B lym-
phocyte development. Adv. Immunol. 59:279–368.
2. Humphrey, J.H. 1981. Tolerogenic or immunogenic activity
of hapten-conjugated polysaccharides correlated with cellular
localization. Eur. J. Immunol. 11:212–220.
3. Lane, P.J., D. Gray, S. Oldfield, and I.C. MacLennan. 1986.
Differences in the recruitment of virgin B cells into antibody
responses to thymus-dependent and thymus-independent
type-2 antigens. Eur. J. Immunol. 16:1569–1575.
4. Oliver, A.M., F. Martin, G.L. Gartland, R.H. Carter, and
J.F. Kearney. 1997. Marginal zone B cells exhibit unique ac-
tivation, proliferative and immunoglobulin secretory re-
sponses.  Eur. J. Immunol. 27:2366–2374.
5. Liu, Y.J., S. Oldfield, and I.C. MacLennan. 1988. Memory B
cells in T cell-dependent antibody responses colonize the
splenic marginal zones. Eur. J. Immunol. 18:355–362.
6. Groeneveld, P.H., T. Erich, and G. Kraal. 1985. In vivo ef-
fects of LPS on B lymphocyte subpopulations. Migration of
marginal zone-lymphocytes and IgD-blast formation in the
mouse spleen. Immunobiology. 170:402–411.
7. Kelsoe, G. 1996. Life and death in germinal centers (redux).
Immunity. 4:107–111.
8. Klinman, N.R. 1997. The cellular origins of memory B cells.
Semin. Immunol. 9:241–247.
9. Duchosal, M.A. 1997. B-cell development and differentia-
tion. Semin. Hematol. 34(Suppl.):2–12.
10. Kearney, J.F., W.J. Won, C. Benedict, C. Moratz, P. Zim-
mer, A. Oliver, F. Martin, and F. Shu. 1997. B cell develop-
ment in mice. Int. Rev. Immunol. 15:207–241.
11. Zlotnik, A., J. Morales, and J.A. Hedrick. 1999. Recent ad-
vances in chemokines and chemokine receptors. Crit. Rev.
Immunol. 19:1–47.
12. Foxman, E.F., J.J. Campbell, and E.C. Butcher. 1997. Multi-
step navigation and the combinatorial control of leukocyte
chemotaxis. J. Cell Biol. 139:1349–1360.
13. Hromas, R., C.H. Kim, M. Klemsz, M. Krathwohl, K. Fife,
S. Cooper, C. Schnizlein-Bick, and H.E. Broxmeyer. 1997.
Isolation and characterization of Exodus-2, a novel C-C
chemokine with a unique 37-amino acid carboxyl-terminal
extension. J. Immunol. 159:2554–2558.
14. Gunn, M.D., V.N. Ngo, K.M. Ansel, E.H. Ekland, J.G. Cys-
ter, and L.T. Williams. 1998. A B-cell-homing chemokine
made in lymphoid follicles activates Burkitt’s lymphoma re-
ceptor-1. Nature. 391:799–803.
15. Legler, D.F., M. Loetscher, R.S. Roos, I. Clark-Lewis, M.
Baggiolini, and B. Moser. 1998. B cell-attracting chemokine
1, a human CXC chemokine expressed in lymphoid tissues,
selectively attracts B lymphocytes via BLR1/CXCR5. J.
Exp. Med. 187:655–660.
16. Campbell, J.J., E.P. Bowman, K. Murphy, K.R. Youngman,
M.A. Siani, D.A. Thompson, L. Wu, A. Zlotnik, and E.C.
Butcher. 1998. 6-C-kine (SLC), a lymphocyte adhesion-trig-
gering chemokine expressed by high endothelium, is an ago-
nists for the MIP-3beta receptor CCR7. J. Cell Biol. 141:
1053–1059.
17. Ngo, V.N., H.L. Tang, and J.G. Cyster. 1998. Epstein-Barr
virus–induced molecule 1 ligand chemokine is expressed by
dendritic cells in lymphoid tissues and strongly attracts naive
T cells and activated B cells. J. Exp. Med. 188:181–191.
18. Kim, C.H., L.M. Pelus, J.R. White, E. Applebaum, K. Jo-
hanson, and H.E. Broxmeyer. 1998. CK beta-11/macro-
phage inflammatory protein-3 beta/EBI1-ligand chemokine
is an efficacious chemoattractant for T and B cells. J. Immunol.
160:2418–2424.
19. Nagira, M., T. Imai, R. Yoshida, S. Takagi, M. Iwasaki, M.
Baba, Y. Tabira, J. Akagi, H. Nomiyama, and O. Yoshie.
1998. A lymphocyte-specific CC chemokine, secondary lym-
phoid tissue chemokine (SLC), is a highly efficient chemoat-
tractant for B cells and activated T cells. Eur. J. Immunol. 28:
1516–1523.
20. Tanaka, Y., T. Imai, M. Baba, I. Ishikawa, M. Uehira, H.
Nomiyama, and O. Yoshie. 1999. Selective expression of
liver and activation-regulated chemokine (LARC) in intesti-
nal epithelium in mice and humans. Eur. J. Immunol. 29:633–
642.
21. Campbell, J.J., S. Qin, K.B. Bacon, C.R. Mackay, and E.C.
Butcher. 1996. Biology of chemokine and classical chemoat-
tractant receptors: differential requirements for adhesion-trig-
gering versus chemotactic responses in lymphoid cells. J. Cell
Biol. 134:255-266.
22. Cyster, J., V.N. Ngo, E.H. Ekland, M.D. Gunn, J.D. Sedg-
wick, and K.M. Ansel. 1999. Chemokines and B-cell homing
to follicles. Curr. Top. Microbiol. Immunol. 246:87–92.
23. Hunte, B.E., S. Hudak, D. Campbell, Y. Xu, and D. Ren-
nick. 1996. flk2/flt3 ligand is a potent cofactor for the growth
of primitive B cell progenitors. J. Immunol. 156:489–496.
24. Veiby, O.P., S.D. Lyman, and S.E. Jacobsen. 1996. Com-
bined signaling through interleukin-7 receptors and flt3 but
not c-kit potently and selectively promotes B-cell commit-
ment and differentiation from uncommitted murine bone
marrow progenitor cells. Blood. 88:1256–1265.
25. Hardy, R.R., C.E. Carmack, S.A. Shinton, J.D. Kemp, and
K. Hayakawa. 1991. Resolution and characterization of pro-B
and pre–pro-B cell stages in normal mouse bone marrow. J.
Exp. Med. 173:1213–1225.
26. Li, Y.S., R. Wasserman, K. Hayakawa, and R.R. Hardy.
1996. Identification of the earliest B lineage stage in mouse1316 Chemokine Responses during B Cell Development
bone marrow. Immunity. 5:527–535.
27. Forster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and
M. Lipp. 1996. A putative chemokine receptor, BLR1, di-
rects B cell migration to defined lymphoid organs and specific
anatomic compartments of the spleen. Cell. 87:1037–1047.
28. Pevzner, V., I. Wolf, R. Burgstahler, R. Forster, and M.
Lipp. 1999. Regulation of expression of chemokine receptor
BLR1/CXCR5 during B cell maturation. Curr. Top. Micro-
biol. Immunol. 246:79–84.
29. Allman, D.M., S.E. Ferguson, and M.P. Cancro. 1992. Pe-
ripheral B cell maturation. I. Immature peripheral B cells in
adults are heat-stable antigenhi and exhibit unique signaling
characteristics. J. Immunol. 149:2533–2540.
30. Loder, F., B. Mutschler, R.J. Ray, C.J. Paige, P. Sideras, R.
Torres, M.C. Lamers, and R. Carsetti. 1999. B cell develop-
ment in the spleen takes place in discrete steps and is deter-
mined by the quality of B cell receptor–derived signals. J.
Exp. Med. 190:75–89.
31. Kroese, F.G., E.C. Butcher, P.A. Lalor, A.M. Stall, and L.A.
Herzenberg. 1990. The rat B cell system: the anatomical lo-
calization of flow cytometry-defined B cell subpopulations.
Eur. J. Immunol. 20:1527–1534.
32. Rose, M.L., M.S. Birbeck, V.J. Wallis, J.A. Forrester, and
A.J. Davies. 1980. Peanut lectin binding properties of germi-
nal centres of mouse lymphoid tissue. Nature. 284:364–366.
33. Butcher, E.C., R.V. Rouse, R.L. Coffman, C.N. Notten-
burg, R.R. Hardy, and I.L. Weissman. 1982. Surface pheno-
type of Peyer’s patch germinal center cells: implications for
the role of germinal centers in B cell differentiation. J. Immu-
nol. 129:2698–2707.
34. Kraal, G., I.L. Weissman, and E.C. Butcher. 1982. Germinal
centre B cells: antigen specificity and changes in heavy chain
class expression. Nature. 298:377–379.
35. Hardy, R.R., K. Hayakawa, J. Haaijman, and L.A. Herzen-
berg. 1982. B-cell subpopulations identified by two-colour
fluorescence analysis. Nature. 297:589–591.
36. Butcher, E.C., and L.J. Picker. 1996. Lymphocyte homing
and homeostasis. Science. 272:60–66.
37. Mebius, R.E., P.R. Streeter, S. Michie, E.C. Butcher, and
I.L. Weissman. 1996. A developmental switch in lymphocyte
homing receptor and endothelial vascular addressin expres-
sion regulates lymphocyte homing and permits CD41
CD32 cells to colonize lymph nodes. Proc. Natl. Acad. Sci.
USA. 93:11019–11024.
38. Weissman, I.L. 1994. Developmental switches in the immune
system. Cell. 76:207–218.
39. Butcher, E.C., M. Williams, K. Youngman, L. Rott, and M.
Briskin. 1999. Lymphocyte trafficking and regional immu-
nity. Adv. Immunol. 72:209–253.
40. Allman, D., J. Li, and R.R. Hardy. 1999. Commitment to
the B lymphoid lineage occurs before DH-JH recombina-
tion. J. Exp. Med. 189:735–740.
41. Cumano, A., C.J. Paige, N.N. Iscove, and G. Brady. 1992.
Bipotential precursors of B cells and macrophages in murine
fetal liver. Nature. 356:612–615.
42. Trentin, L., C. Agostini, M. Facco, F. Piazza, A. Perin, M.
Siviero, C. Gurrieri, S. Galvan, F. Adami, R. Zambello, and
G. Semenzato. 1999. The chemokine receptor CXCR3 is
expressed on malignant B cells and mediates chemotaxis. J.
Clin. Invest. 104:115–121.
43. Rolink, A., E. ten Boekel, F. Melchers, D.T. Fearon, I.
Krop, and J. Andersson. 1996. A subpopulation of B2201
cells in murine bone marrow does not express CD19 and
contains natural killer cell progenitors. J. Exp. Med. 183:187–
194.
44. Youn, B.S., I.K. Jang, H.E. Broxmeyer, S. Cooper, N.A.
Jenkins, D.J. Gilbert, N.G. Copeland, T.A. Elick, M.J.
Fraser, Jr., and B.S. Kwon. 1995. A novel chemokine, mac-
rophage inflammatory protein-related protein-2, inhibits col-
ony formation of bone marrow myeloid progenitors. J. Im-
munol. 155:2661–2667.
45. Broxmeyer, H.E., S. Cooper, G. Cacalano, N.L. Hague, E.
Bailish, and M.W. Moore. 1996. Involvement of interleukin
(IL)-8 receptor in negative regulation of myeloid progenitor
cells in vivo: evidence from mice lacking the murine IL-8 re-
ceptor homologue. J. Exp. Med. 184:1825–1832.
46. Patel, V.P., B.L. Kreider, Y. Li, H. Li, K. Leung, T. Salcedo,
B. Nardelli, V. Pippalla, S. Gentz, R. Thotakura, et al. 1997.
Molecular and functional characterization of two novel hu-
man C-C chemokines as inhibitors of two distinct classes of
myeloid progenitors. J. Exp. Med. 185:1163–1172.
47. Youn, B.S., S.M. Zhang, H.E. Broxmeyer, S. Cooper, K.
Antol, M. Fraser, Jr., and B.S. Kwon. 1998. Characterization
of CKbeta8 and CKbeta8-1: two alternatively spliced forms
of human beta-chemokine, chemoattractants for neutrophils,
monocytes, and lymphocytes, and potent agonists at CC
chemokine receptor 1. Blood. 91:3118–3126.
48. Quackenbush, E.J., B.K. Wershil, V. Aguirre, and J.C. Guti-
errez-Ramos. 1998. Eotaxin modulates myelopoiesis and
mast cell development from embryonic hematopoietic pro-
genitors. Blood. 92:1887–1897.
49. Kim, C.H., L.M. Pelus, E. Appelbaum, K. Johanson, N. An-
zai, and H.E. Broxmeyer. 1999. CCR7 ligands, SLC/
6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC,
are chemoattractants for CD561CD162 NK cells and late
stage lymphoid progenitors. Cell. Immunol. 193:226–235.
50. D’Apuzzo, M., A. Rolink, M. Loetscher, J.A. Hoxie, I.
Clark-Lewis, F. Melchers, M. Baggiolini, and B. Moser.
1997. The chemokine SDF-1, stromal cell-derived factor 1,
attracts early stage B cell precursors via the chemokine recep-
tor CXCR4. Eur. J. Immunol. 27:1788–1793.
51. Ma, Q., D. Jones, and T.A. Springer. 1999. The chemokine
receptor CXCR4 is required for the retention of B lineage
and granulocytic precursors within the bone marrow mi-
croenvironment.  Immunity. 10:463–471.
52. Forster, R., T. Emrich, E. Kremmer, and M. Lipp. 1994. Ex-
pression of the G-protein–coupled receptor BLR1 defines
mature, recirculating B cells and a subset of T-helper mem-
ory cells. Blood. 84:830–840.
53. Soto, H., W. Wang, R.M. Strieter, N.G. Copeland, D.J.
Gilbert, N.A. Jenkins, J. Hedrick, and A. Zlotnik. 1998. The
CC chemokine 6Ckine binds the CXC chemokine receptor
CXCR3. Proc. Natl. Acad. Sci. USA. 95:8205–8210.
54. Gunn, M.D., K. Tangemann, C. Tam, J.G. Cyster, S.D.
Rosen, and L.T. Williams. 1998. A chemokine expressed in
lymphoid high endothelial venules promotes the adhesion
and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci.
USA. 95:258–263.
55. Warnock, R.A., J.J. Campbell, M.E. Dorf, L.M. McEvoy,
and E.C. Butcher. 2000. The role of chemokines in the mi-
croenvironmental control of T versus B cell arrest in Peyer’s
patch high endothelial venules. J. Exp. Med. 191:77–88.
56. Pachynski, R.K., S.W. Wu, M.D. Gunn, and D.J. Erle.
1998. Secondary lymphoid-tissue chemokine (SLC) stimu-
lates integrin alpha 4 beta 7-mediated adhesion of lympho-
cytes to mucosal addressin cell adhesion molecule-1 (MAd-1317 Bowman et al.
CAM-1) under flow. J. Immunol. 161:952–956.
57. Stein, J.V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Na-
kano, M.D. Gunn, A. Matsuzawa, E.J. Quackenbush, M.E.
Dorf, and U.H. von Andrian. 2000. The CC chemokine
thymus-derived chemotactic agent 4 (TCA-4, secondary
lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lym-
phocyte function–associated antigen 1–mediated arrest of
rolling T lymphocytes in peripheral lymph node high endo-
thelial venules. J. Exp. Med. 191:61–76.
58. Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Ren-
ner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates
the primary immune response by establishing functional mi-
croenvironments in secondary lymphoid organs. Cell. 99:
23–33.
59. Liao, F., R.L. Rabin, C.S. Smith, G. Sharma, T.B. Nutman,
and J.M. Farber. 1999. CC-chemokine receptor 6 is ex-
pressed on diverse memory subsets of T cells and determines
responsiveness to macrophage inflammatory protein 3 alpha.
J. Immunol. 162:186–194.
60. Rossi, D.L., A.P. Vicari, K. Franz-Bacon, T.K. McClanahan,
and A. Zlotnik. 1997. Identification through bioinformatics
of two new macrophage proinflammatory human chemo-
kines: MIP-3alpha and MIP-3beta. J. Immunol. 158:1033–
1036.
61. Dieu, M.C., B. Vanbervliet, A. Vicari, J.M. Bridon, E. Old-
ham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, and
C. Caux. 1998. Selective recruitment of immature and ma-
ture dendritic cells by distinct chemokines expressed in differ-
ent anatomic sites. J. Exp. Med. 188:373–386.
62. Varona, R., A. Zaballos, J. Gutierrez, P. Martin, F. Roncal,
J.P. Albar, C. Ardavin, and G. Marquez. 1998. Molecular
cloning, functional characterization and mRNA expression
analysis of the murine chemokine receptor CCR6 and its
specific ligand MIP-3alpha. FEBS Lett. 440:188–194.
63. Bleul, C.C., J.L. Schultze, and T.A. Springer. 1998. B lym-
phocyte chemotaxis regulated in association with microana-
tomic localization, differentiation state, and B cell receptor
engagement. J. Exp. Med. 187:753–762.
64. Jenh, C.H., M.A. Cox, H. Kaminski, M. Zhang, H. Byrnes,
J. Fine, D. Lundell, C.C. Chou, S.K. Narula, and P.J.
Zavodny. 1999. Cutting edge: species specificity of the CC
chemokine 6Ckine signaling through the CXC chemokine
receptor CXCR3: human 6Ckine is not a ligand for the hu-
man or mouse CXCR3 receptors. J. Immunol. 162:3765–
3769.